While
most Rh–N-heterocyclic carbene (NHC) complexes currently
investigated in anticancer research contain a Rh(III) metal center,
an increasing amount of research is focusing on the cytotoxic activity
and mode of action of square-planar [RhCl(COD)(NHC)] (where COD =
1,5-cyclooctadiene) which contains a Rh(I) center. The enzyme thioredoxin
reductase (TrxR) and the protein albumin have been proposed as potential
targets,
but the molecular processes taking place upon protein interaction
remain elusive. Herein, we report the preparation of peptide-conjugated
and its nonconjugated parent [RhCl(COD)(NHC)] complexes, an in-depth
investigation of both their stability in solution, and a crystallographic
study of protein interaction. The organorhodium compounds showed a
rapid loss of the COD ligand and slow loss of the NHC ligand in aqueous
solution. These ligand exchange reactions were reflected in studies
on the interaction with hen egg white lysozyme (HEWL) as a model protein
in single-crystal X-ray crystallographic investigations. Upon treatment
of HEWL with an amino acid functionalized [RhCl(COD)(NHC)] complex,
two distinct rhodium adducts were found initially after 7 d of incubation
at His15 and after 4 weeks also at Lys33. In both cases, the COD and
chlorido ligands had been substituted with aqua and/or hydroxido ligands.
While the histidine (His) adduct also indicated a loss of the NHC
ligand, the lysine (Lys) adduct retained the NHC core derived from
the amino acid l-histidine. In either case, an octahedral
coordination environment of the metal center indicates oxidation to
Rh(III). This investigation gives the first insight on the interaction
of Rh(I)(NHC) complexes and proteins at the molecular level.